| Name | ldn-211904 |
|---|---|
| Synonyms |
LDN211904
N-(2-chlorophenyl)-6-(piperidin-4-yl)imidazo[1,2-a]pyridine-3-carboxamide oxalate |
| Description | LDN-211904 oxalate (compound 32) is a potent and selective EphB3 inhibitor with an IC50 of 0.079 µM. LDN-211904 oxalate shows good metabolic stability in mouse liver microsomes. LDN-211904 oxalate with cetuximab could be effective in inhibiting STAT3-activated CSC stemness and cetuximab resistance in CRC[1][2]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 0.079 µM (EphB3)[1] |
| References |
| Molecular Formula | C21H21ClN4O5 |
|---|---|
| Molecular Weight | 444.86800 |
| Exact Mass | 444.12000 |
| PSA | 133.03000 |
| LogP | 3.26440 |